SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001616824-24-000006
Filing Date
2024-01-11
Accepted
2024-01-10 17:39:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D/A 69451
2 ex99_3.htm EX-99.3 2351
3 ex99_3.pdf EX-99.3 288739
  Complete submission text file 0001616824-24-000006.txt   471313
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address 156 S. FIRST STREET ZIONSVILLE IN 46077 317-344-6689
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

IRS No.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89959 | Film No.: 24527451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)